Delivery Order SPE2DE24D0021-SPE2D626F01EZ
- Not listed
- Fisher Scientific Company L.L.C. was awarded a delivery order valued at $2,940 on January 8, 2026, for BinaxNOW COVID-19 antigen testing kits to support the Defense Department's Medical Supply Chain. The contract is a fixed-price delivery order with economic price adjustment provisions, with a completion deadline of January 15, 2026. As a child contract, this award represents an individual order issued under a larger indefinite delivery vehicle or blanket purchase agreement. No set-aside...
- Fisher Scientific Company L.L.C. was awarded a delivery order valued at $1,159.12 on November 4, 2025, for the provision of BinaxNow COVID antigen testing kits to support the Department of Defense Medical Supply Chain. The contract is structured as a fixed-price delivery order with economic price adjustment provisions and carries an ultimate completion date of November 12, 2025. Performance will be executed from Fisher Scientific's location in Pittsburgh, Pennsylvania. This award represents a...
- Fisher Scientific Company L.L.C. has been awarded a delivery order valued at $2,205.00 for BinaxNow COVID-19 antigen OTC test kits (12 tests per 2-test case) by the Defense Medical Supply Chain federal agency. The contract, awarded on September 9, 2025, with an ultimate completion date of September 16, 2025, utilizes a fixed price with economic price adjustment pricing structure. The place of performance is Pittsburgh, Pennsylvania. This delivery order represents a child contract, indicating...
- Fisher Scientific Company L.L.C. has been awarded a $4.3K delivery order for BinaxNOW COVID-19 antigen testing kits under a fixed-price contract with economic price adjustment provisions. The award was issued on January 7, 2026, with an ultimate completion date of January 14, 2026, and will be performed in Pittsburgh, Pennsylvania. This delivery order was issued without a set-aside designation, indicating open competition, and is funded by the Department of Defense's Medical Supply Chain...
- Fisher Scientific Company L.L.C. received a delivery order award on August 22, 2025, for the procurement of BinaxNOW COVID-19 antigen testing kits. The contract carries a ceiling value of $2,213.20 and is structured as a fixed-price agreement with economic price adjustment provisions. Funding originates from the Medical Supply Chain division within the Department of Defense. The place of performance is listed as Pittsburgh, PA. This delivery order represents a child contract, indicating it falls...
- Fisher Scientific Company L.L.C. was awarded a delivery order valued at $1,960 on January 13, 2026, for the provision of BinaxNOW COVID-19 antigen testing kits to support the Department of Defense's Medical Supply Chain. This contract represents a child delivery order issued under a larger procurement vehicle and utilizes a fixed-price contract structure with economic price adjustment provisions. The performance location is Pittsburgh, Pennsylvania, and the contract is scheduled for completion...
- Fisher Scientific Company L.L.C. was awarded a delivery order valued at $8,036.00 for BINAXNOW COVID-19 40S test kits on August 15, 2025, by the Defense Medical Supply Chain, with an ultimate completion date of August 22, 2025. This is a fixed price contract with economic price adjustment provisions and carries no set-aside designation, reflecting open competition procurement. The contract specifies performance in Pittsburgh, PA 15275. As a child contract under a larger procurement vehicle, this...
- The U.S. Department of Defense Medical Supply Chain awarded a delivery order valued at $1,617.00 to Fisher Scientific Company L.L.C. on August 26, 2025, for the procurement of BinaxNOW COVID-19 antigen tests (12 tests per 2-test case). This fixed-price contract with economic price adjustment provisions is categorized as a child contract and does not utilize a set-aside designation, indicating open competition among qualified vendors. The place of performance is Pittsburgh, Pennsylvania, with...
- Fisher Scientific Company L.L.C. was awarded a delivery order on August 4, 2025, for BinaxNow COVID-19 antigen over-the-counter rapid test kits (12 tests per 2-count case) valued at $1,311.20. This fixed-price delivery order with economic price adjustment was issued by the Medical Supply Chain division within the Department of Defense and is set to be completed by August 11, 2025. The contract represents a child award under a larger vehicle and specifies performance in Pittsburgh,...
- The U.S. Department of Defense has awarded a $5,184 fixed-price delivery order contract to Fisher Scientific Company L.L.C. for the provision of 4,565,083,211 BinaxNOW COVID-19 antigen test kits. This order was placed under the Medical Supply Chain contract with the Defense agency. The contract has an ultimate completion date of July 15, 2024 and does not utilize any set-aside designations. Fisher Scientific, a large for-profit limited liability company, has a strong track record of supporting...
- SPE2DE24D0021Indefinite Delivery Contract
- SPE2DE24D0021-SPE2D626F01EZDelivery Order
The Department of Defense Medical Supply Chain awarded a $2,897.80 fixed-price delivery order with economic price adjustment to Fisher Scientific Company L.L.C. for BinaxNow COVID-19 40-count test kits on January 12, 2026. This contract represents a child award under a larger indefinite delivery vehicle and carries an ultimate completion date of January 20, 2026, indicating a near-term fulfillment requirement. No set-aside designation was applied to this procurement, reflecting open competition among qualified vendors. Performance will be executed at Fisher Scientific's principal location in Pittsburgh, Pennsylvania. Fisher Scientific, a major federal vendor registered in the System for Award Management since 2001, maintains an extensive portfolio supplying laboratory equipment, diagnostic products, and medical supplies across multiple federal agencies. The company's relationship with the Department of Defense Medical Supply Chain reflects its established capabilities in providing specialized diagnostic test kits and laboratory supplies. This delivery order for rapid COVID-19 diagnostic testing supports the Department of Defense's ongoing medical readiness and healthcare delivery operations, leveraging Fisher Scientific's proven expertise in sourcing and delivering time-sensitive medical diagnostic products to federal customers.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.9k | 1/11/26 |